Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Interactive debate.

International Journal of Clinical Practice. Supplement

|January 6, 2000

Summary

This summary is machine-generated.

This European symposium explored future therapeutic options for evolving diseases. Panelists discussed preferred first-line, second-line, and salvage therapies, alongside compliance and drug resistance challenges.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The EuroSIDA study: 25 years of scientific achievements.

HIV medicine·2019

Same author

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Journal of neurovirology·2018

Same author

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Journal of neurovirology·2017

Same author

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.

International journal of STD & AIDS·2016

Same author

Editorial.

HIV medicine·2016

Same author

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

PloS one·2015

Same journal

Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.

International journal of clinical practice. Supplement·2015

Same journal

Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus-related diseases: a single centre study.

International journal of clinical practice. Supplement·2015

Same journal

Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.

International journal of clinical practice. Supplement·2015

Same journal

Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.

International journal of clinical practice. Supplement·2015

Same journal

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

International journal of clinical practice. Supplement·2015

Same journal

Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.

International journal of clinical practice. Supplement·2015

See all related articles

Area of Science:

Medical Therapeutics
Clinical Practice Guidelines
Pharmacology

Background:

A European symposium convened experts to discuss evolving therapeutic strategies.
Case studies were utilized to explore hypothetical future treatment scenarios.

Observation:

An interactive voting session facilitated panel discussions on treatment preferences.
Discussions centered on first-line, second-line, and salvage therapy options.

Findings:

Key considerations included patient compliance and the emergence of drug resistance.
Future therapeutic landscapes were projected, incorporating investigational drugs.

Implications:

The findings offer insights into potential future clinical practice for complex diseases.
Understanding future treatment paradigms is crucial for managing evolving therapeutic challenges.